Approval · Notice of Compliance 5552 · 2004

TRYPTAN: Notice of Compliance 5552

Issued October 13, 2004

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 5552
Date: October 13, 2004
Company: Valeant Canada LpLaval, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Adjunct in the management of affective disorders

Products in this notice

Brand	DIN	Status today
TRYPTAN	02239326	Marketed
TRYPTAN	02029456	Marketed
TRYPTAN	02239327	Marketed
TRYPTAN	00654531	Marketed
TRYPTAN	00718149	Marketed

Medicinal ingredients

TRYPTOPHAN 250 MG per TAB
TRYPTOPHAN 500 MG per TAB
TRYPTOPHAN 750 MG per TAB
TRYPTOPHAN 1 G per TAB
TRYPTOPHAN 500 MG per CAP